Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Brett

Showing results (101-110 of 111) with videos related to

Pageof 12
Sort By:
Clinical Toxicology (Philadelphia, Pa.)|October 1, 2024
Poisoning and envenomation linkage to evaluate outcomes and clinical variation in Australia (PAVLOVA): a longitudinal data-linkage cohort of acute poisonings, envenomations, and adverse drug reactions in New South Wales, Australia, 2011-2020Rose Cairns, Firouzeh Noghrehchi, Jacques E Raubenheimer, et al.
Neuroscience and Biobehavioral Reviews|February 4, 2024
Who are you after psychedelics? A systematic review and a meta-analysis of the magnitude of long-term effects of serotonergic psychedelics on cognition/creativity, emotional processing and personalityIvana Solaja, Kate Haldane, Natasha Mason, et al.
Drug and Alcohol Dependence|May 18, 2025
Exploring psychedelic experiences among people who regularly use methamphetamine: Findings from an international surveyDilara Bahceci, Krista Siefried, Maureen Steele, et al.
BMJ Open|February 10, 2025
Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychothera<u>p</u>y for methamphetamine use disorder (the KAPPA trial)Kathryn Fletcher, Nadine Ezard, Krista J Siefried, et al.
BMJ Open|February 7, 2025
Trial protocol of an open-label pilot study of oral <u>na</u>ltrexone-<u>bu</u>propion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial)Krista J Siefried, Liam Acheson, Brendan Clifford, et al.
Drug and Alcohol Dependence|June 20, 2020
Toxicological analysis of serious drug-related harm among electronic dance music festival attendees in New South Wales, Australia: A consecutive case seriesEleanor Black, Laksmi Govindasamy, Robin Auld, et al.
Clinical Pharmacology and Therapeutics|November 15, 2020
Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series AnalysisSophie L Stocker, Jane E Carland, Stephanie E Reuter, et al.
Drug and Alcohol Review|January 26, 2026
Expanding Access to Addiction Medicine Specialist Care in Regional New South Wales, Australia Through TelehealthClare S Smylie, Carl I Moller, Lucy McWilliams, et al.
Haematologica|November 14, 2024
Germline genetics, disease, and exposure to medication influence longitudinal dynamics of clonal hematopoiesisTaralynn Mack, Yash Pershad, Caitlyn Vlasschaert, et al.
BMJ Open|November 27, 2025
Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settingsLiam S Acheson, Krista J Siefried, Nicholas Lintzeris, et al.
Pageof 12

Showing results (101-110 of 111) with videos related to

Sort By:
Pageof 12
Clinical Toxicology (Philadelphia, Pa.)|October 1, 2024
Poisoning and envenomation linkage to evaluate outcomes and clinical variation in Australia (PAVLOVA): a longitudinal data-linkage cohort of acute poisonings, envenomations, and adverse drug reactions in New South Wales, Australia, 2011-2020Rose Cairns, Firouzeh Noghrehchi, Jacques E Raubenheimer, et al.
Neuroscience and Biobehavioral Reviews|February 4, 2024
Who are you after psychedelics? A systematic review and a meta-analysis of the magnitude of long-term effects of serotonergic psychedelics on cognition/creativity, emotional processing and personalityIvana Solaja, Kate Haldane, Natasha Mason, et al.
Drug and Alcohol Dependence|May 18, 2025
Exploring psychedelic experiences among people who regularly use methamphetamine: Findings from an international surveyDilara Bahceci, Krista Siefried, Maureen Steele, et al.
BMJ Open|February 10, 2025
Protocol of an open-label safety and feasibility pilot study of ketamine-assisted psychothera<u>p</u>y for methamphetamine use disorder (the KAPPA trial)Kathryn Fletcher, Nadine Ezard, Krista J Siefried, et al.
BMJ Open|February 7, 2025
Trial protocol of an open-label pilot study of oral <u>na</u>ltrexone-<u>bu</u>propion combination pharmacotherapy for the treatment of methamphetamine use disorder (the NABU trial)Krista J Siefried, Liam Acheson, Brendan Clifford, et al.
Drug and Alcohol Dependence|June 20, 2020
Toxicological analysis of serious drug-related harm among electronic dance music festival attendees in New South Wales, Australia: A consecutive case seriesEleanor Black, Laksmi Govindasamy, Robin Auld, et al.
Clinical Pharmacology and Therapeutics|November 15, 2020
Evaluation of a Pilot Vancomycin Precision Dosing Advisory Service on Target Exposure Attainment Using an Interrupted Time Series AnalysisSophie L Stocker, Jane E Carland, Stephanie E Reuter, et al.
Drug and Alcohol Review|January 26, 2026
Expanding Access to Addiction Medicine Specialist Care in Regional New South Wales, Australia Through TelehealthClare S Smylie, Carl I Moller, Lucy McWilliams, et al.
Haematologica|November 14, 2024
Germline genetics, disease, and exposure to medication influence longitudinal dynamics of clonal hematopoiesisTaralynn Mack, Yash Pershad, Caitlyn Vlasschaert, et al.
BMJ Open|November 27, 2025
Study protocol for a randomised controlled trial to determine the efficacy of lisdexamfetamine for the treatment of acute methamphetamine withdrawal in inpatient settingsLiam S Acheson, Krista J Siefried, Nicholas Lintzeris, et al.
Pageof 12